GlassScriptPhysician profile
Lukas Peter Zebala
NPI 1780779124
$9,708.00
in general payments reported to CMS, 2019-2025
20 companies · $2,129 in 2025
The $2,129 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $694 · 2020: $148 · 2021: $2,349 · 2022: $168 · 2023: $3,679 · 2024: $541 · 2025: $2,129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,522 · Food and Beverage: $2,827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,522.34 |
| Food and Beverage | $2,826.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $3,390.59 | 2023 | Other - Miscellaneous, Lif |
| Nuvasive, INC. | $1,866.05 | 2020-2021 | |
| Medical Device Business Services, INC. | $1,170.46 | 2025 | Velys |
| Depuy Synthes Sales INC. | $1,138.86 | 2020-2025 | Velys, Teligen, Expedium |
| Globus Medical, INC. | $888.60 | 2019-2025 | Reline |
| Medtronic, INC. | $402.93 | 2021-2025 | Cd Horizon Spinal System, Mazor X System, Adaptix Interbody System With Titan Nanolock Surface Technology |
| Intrinsic Therapeutics | $197.51 | 2021 | |
| Providence Medical Technology, INC. | $117.03 | 2023 | |
| Prosidyan, INC | $91.00 | 2021 | |
| Ethicon US, LLC | $75.21 | 2024-2025 | Dermabond Prineo |
| Orthofix Medical, INC. | $63.69 | 2024-2025 | Stim On Track, Spinal-Stim |
| Seaspine Orthopedics Corporation | $55.57 | 2021 | |
| Si-Bone, INC. | $54.03 | 2024 | |
| Biocomposites INC | $41.64 | 2025 | Stimulan |
| Lightbody Medical Technologies INC | $33.66 | 2024-2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $31.17 | 2024 | Zynrelef |
| Brainlab, INC. | $25.97 | 2021 | |
| Smith+Nephew, INC. | $23.68 | 2024 | Renasys Go V2 Home, Pico 14, Acticoat 4" X 4" |
| Siemens Medical Solutions USA, INC. | $20.75 | 2022 | |
| Kuros Biosciences USA, INC | $19.60 | 2024 | Magnetos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lukas Zebala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.